leisure time -WSS

leisure time

author：knowledge 2025-09-27 17:02:05 - browse：39837

illustration of a colorful DNA strand, partly broken into pieces. -- health coverage from STAT — Adobe

BALTIMORE — An ambitious effort to cure HIV with CRISPR genome editing fell short in an early clinical trial, investigators announced Friday morning.

In the study, run by Excision BioTherapeutics, researchers tried to use the gene editing tool to address a chief reason HIV has been so hard to cure. While antiviral drugs can clear patients of replicating virus, HIV is able to worm its way into a patients’ own DNA in certain cells. If the patient ever stops taking medicines, those cells start pumping out HIV particles and the infection roars back.

Researchers hoped they could send CRISPR to those cells and, by cutting the HIV DNA lurking there at two spots, slice out the virus. In the Phase 1 trial, investigators administered the treatment to five patients. They then took three of them off conventional antiviral treatment.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Telehealth startups are trying to fill the menopause care vacuum

hotspot

WSS

NIH fellows want a pay raise. Will that mean less money for grants?

Hormonal contraceptives don’t actually treat endometriosis

Delta passengers in Vegas fall sick while waiting on flight in triple

NIH fellows want a pay raise. Will that mean less money for grants?

In rare move, senator releases unverified FBI source report alleging Biden bribe

Are infertility treatments 'essential' during the Covid

Wikipedia

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

leisure time

Bright Health sells Medicare Advantage business to Molina

Why 40% Americans with Parkinson’s don’t see a neurologist

Trump demands the U.S. pay no more for drugs than other countries … again

Beach reads and more: STAT's 2023 summer book list

Novavax promises a turnaround & Lilly roils the obesity market

Sanders wants to replace patents with prizes for drug inventions

Wildfire smoke exposes gaps in outdoor worker protections

Charles Manson follower Leslie Van Houten released from prison after 53 years

23andMe had bad news about my health. I wish a person had delivered it

Petition to FDA: Get the lead out of consumer hair dyes

focus

US jobless claims fall again as labor market continues to flash strength

US jobless claims fall again as labor market continues to flash strength

Leqembi, other new Alzheimer’s drugs require better biomarkers

Lecanemab for Alzheimer's is coming. Is the health system ready?

Retired US general questions alleged Putin, Prigozhin meeting

Beach reads and more: STAT's 2023 summer book list

hotspot

focus

entertainment

focus